1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis is a broad parent announcement for small research grants. NCATS participates in this NOFO, indicating interest in supporting smaller-scale translational science projects aligned with its mission.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligibility for R03 grants is generally broad, including institutions of higher education, non-profits, small businesses, and state/local governments. Specific eligibility should be confirmed in the full NOFO. Confirm the full requirements in the official notice before applying.
Applications for NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) are due January 7, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) (NCATS participation via NOT-TR-26-011). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articleNOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read article